Sanofi (SNY) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Sanofi (SNY) quarterly earnings & revenue
Sanofi (SNY) reported revenue of $13.06B for Q1 2026, up 6.0% year-over-year, with net income of $1.88B and diluted EPS of $0.78.
Over the last four reported quarters, Sanofi generated $55.02B in revenue and $8.78B in net income.
Sanofi's next earnings report is scheduled for July 30, 2026 before market open; analysts estimate EPS of $1.09.
Sanofi quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $13.06B | +6.0% | $1.88B | $0.78 |
| Q4 2025 | $14.18B | +59.9% | $-930.71M | $-1.70 |
| Q3 2025 | $15.30B | -7.0% | $3.26B | $1.32 |
| Q2 2025 | $12.47B | -5.7% | $4.58B | $1.86 |
| Q1 2025 | $12.32B | +9.0% | $2.18B | $0.88 |
| Q4 2024 | $8.87B | -37.5% | $579.81M | $0.41 |
| Q3 2024 | $16.45B | +11.5% | $3.27B | $1.31 |
| Q2 2024 | $13.22B | +6.5% | $1.29B | $0.52 |
Sanofi (SNY) — frequently asked questions
When does Sanofi (SNY) report earnings next?
Sanofi is expected to report earnings on July 30, 2026 before market open. Analysts estimate EPS of $1.09.
What was SNY's revenue last quarter?
Sanofi reported revenue of $13.06B in Q1 2026, up 6.0% from the same quarter a year earlier.
What was SNY's EPS last quarter?
Sanofi reported diluted EPS of $0.78 in Q1 2026.
Is Sanofi profitable?
Sanofi is currently profitable, with $8.78B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)